Re: Excellent Article and Editorial from a ish Newspaper

[Guest guest]

Yep, we deserve safeguards. They're going to safeguard the heck out of us

as we continue to lose abilities they all take for granted. Look at the

side effects from the ABCR's and compare them to the benefits. Where are

the safeguards there? The LDN users are a large group of people. If there

were truly any dangerous side effects we would surely know by now.

I wonder if the steam coming out of my ears will curl my hair. I always

wanted naturally curly hair.

----- Original Message -----

From: " fauquiernews " <printman@...>

<low dose naltrexone >

Sent: Tuesday, April 13, 2004 9:21 AM

Subject: [low dose naltrexone] Excellent Article and Editorial from a ish

Newspaper

MS victim finds hope in heroin users' drug

The Herald - Glasgow,Scotland

<http://www.theherald.co.uk/13809.shtml>

excerpt:

" She decided to try the drug last April. " The first thing I noticed,

lying in bed, was that the numbness in my back had improved, " she

said. Stiffness and fatigue also began to fade and - a particular

milestone - she managed to complete her daughter's student loan

forms, all 14 pages.

" This morning I have got up, worked on my computer, cooked and tidied

up, " she said. " In a short while we are going to go out. Prior to

taking low dose Naltrexone I could not do anything before late

morning. "

It costs Mrs McDevitt £72 for a three month supply of the drug,

even though heroin addicts are able to get it for free to help

control their cravings.

The drug has not yet been licensed for MS sufferers, forcing them to

buy it privately. "

SAFEGUARD for MS sufferers

The Herald - Glasgow,Scotland,UK

<http://www.theherald.co.uk/13811.shtml>

excerpt:

" The answer lies not in making Naltrexone available to all on demand

today, but in holding trials specifically among people with MS, as

some are already demanding. That will be of little comfort to those

who fear that a further round of expensive testing will only delay

the introduction of the drug on the NHS for people with MS. But it is

essential that it is tested among a wide range of people with the

condition to find out if there are any side effects. Evidence from

among a small sample of users, albeit encouraging, is not the same as

a proper trial. MS may be a uniquely debilitating condition but those

who suffer from it have a right to expect the same safeguards as

every other patient. "

[Guest guest]

At last some " main stream media " types are starting to sit up and

take notice. Of course, I don't think they need trials to make sure

LDN is safe, there is enough data that takes care of that already.

Trials to determine exactly how effective LDN is would be nice.

Bottom line is for all those folks who can't or won't fight to get

LDN and want it, any step in the right direction is good. Media

attention like this can only be beneficial.